Publication:
The efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNase

dc.contributor.authorGençoğlu, M. Y.
dc.contributor.authorTuğcu, G. D.
dc.contributor.authorSoydaş, S. S. Akyan
dc.contributor.authorCinel, G.
dc.contributor.authorEmiralioglu, N.
dc.contributor.authorYalçın, E.
dc.contributor.authorKiper, N.
dc.contributor.authorSen, V
dc.contributor.authorAltintas, D. Ufuk
dc.contributor.authorCokugras, H.
dc.contributor.authorKilinc, A. Ayzit
dc.contributor.authorYazan, H.
dc.contributor.authorUnal, G.
dc.contributor.authorYilmaz, A., I
dc.contributor.authorCaglar, H. T.
dc.contributor.authorDamadoglu, E.
dc.contributor.authorIrmak, I.
dc.contributor.authorDemir, E.
dc.contributor.authorOzturk, G.
dc.contributor.authorBingol, A.
dc.contributor.authorBasaran, E.
dc.contributor.authorSapan, N.
dc.contributor.authorAslan, A. T.
dc.contributor.authorAsfuroglu, P.
dc.contributor.authorHarmanci, K.
dc.contributor.authorKose, M.
dc.contributor.authorHangul, M.
dc.contributor.authorOzdemir, A.
dc.contributor.authorOzcan, G.
dc.contributor.authorGayretli, Z. G.
dc.contributor.authorKeskin, O.
dc.contributor.authorYuksel, H.
dc.contributor.authorOzdogan, S.
dc.contributor.authorTopal, E.
dc.contributor.authorCaltepe, G.
dc.contributor.authorCan, D.
dc.contributor.authorEkren, P. Korkmaz
dc.contributor.authorKilic, M.
dc.contributor.authorEyuboglu, T. Sismanlar
dc.contributor.authorPekcan, S.
dc.contributor.authorCobanoglu, N.
dc.contributor.authorCakir, E.
dc.contributor.authorOzcelik, U.
dc.contributor.authorDogru, D.
dc.contributor.buuauthorSAPAN, NİHAT
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.departmentÇocuk Alerji Bilim Dalı
dc.contributor.researcheridFUI-8766-2022
dc.date.accessioned2024-12-04T12:55:23Z
dc.date.available2024-12-04T12:55:23Z
dc.date.issued2022-09-04
dc.descriptionBu çalışma, 04-06, Eylül 2022 tarihlerinde Barcelona[İspanya]’da düzenlenen International Congress of the European-Respiratory-Society (ERS) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Respiratory Soc
dc.identifier.doi10.1183/13993003.congress-2022.4008
dc.identifier.issn0903-1936
dc.identifier.issueSupplement 66
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2022.4008
dc.identifier.urihttps://publications.ersnet.org/content/erj/60/suppl66/4008
dc.identifier.urihttps://hdl.handle.net/11452/48888
dc.identifier.volume60
dc.identifier.wos000893392405429
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherEuropean Respiratory Soc Journals Ltd
dc.relation.journalEuropean Respiratory Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectRespiratory system
dc.titleThe efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNase
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı/Çocuk Alerji Bilim Dalı
relation.isAuthorOfPublicationcc312521-b6b8-4031-a0a0-b06b35291a1c
relation.isAuthorOfPublication.latestForDiscoverycc312521-b6b8-4031-a0a0-b06b35291a1c

Files